Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)

被引:11
作者
Benner, Joshua S.
Cherry, Spencer B.
Erhardt, Leif
Fernandes, Michele
Flammer, Martina
Gaciong, Zbigniew
Girerd, Xavier
Johnson, Eric S.
Garcia-Puig, Juan
Sturkenboom, Miriam C. J. M.
Sun, William
机构
[1] ValueMed Res LLC, Falls Church, VA 22046 USA
[2] Pfizer Inc, New York, NY USA
[3] Med Univ Warsaw, Dept Internal Med & Hypertens, Warsaw, Poland
[4] Hop La Pitie Salpetriere, Dept Endocrinol, Cardiov Prevent Unit, Paris, France
[5] Graunt & Co, LLC, Seattle, WA USA
[6] Hosp La Paz, Madrid, Spain
[7] Erasmus Univ, Med Ctr, Dept Biostat & Epidemiol, Rotterdam, Netherlands
关键词
blood pressure; hypertension; coronary heart disease; randomized controlled trials; risk assessment; framingham;
D O I
10.1016/j.cct.2007.03.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To test the primary study hypothesis that a physician-delivered coronary heart disease risk evaluation and communication program can lower patients' predicted 10-year risk of myocardial infarction or death due to coronary heart disease by 10% within 6 months compared to usual care. Design: Prospective, parallel group, open-label, controlled, cluster-randomized multinational trial; the study site is the unit of randomization. Setting: Patients were recruited from 106 general practices located in nine European countries. Patients: Men and women aged 45 to 64 (N= 1500) with a documented history of hypertension (treated or untreated), systolic blood pressure >= 140 mmHg (or >= 130 mmEg in the presence of renal or kidney disease), no history of cardiovascular disease, and a predicted 10-year risk of myocardial infarction or death due to coronary heart disease >= 10%. Intervention: Sites were randomized to deliver a physician-directed coronary heart disease risk communication and education program or usual care. The intervention program included informing patients of their 10-year risk of myocardial infarction or death due to coronary heart disease, educating patients about modifiable risk factors and their control, and three follow-up phone calls by a physician or study nurse. Main outcome measure: Predicted 10-year risk of myocardial infarction or death due to coronary heart disease at 6 months. Conclusions: REACH OUT will evaluate a novel, patient-focused, physician-implemented application of coronary heart disease risk equations. Results of the study will be of practical relevance to physicians, health care organizations, and those who issue clinical guidelines for the reduction of cardiovascular risk. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:662 / 673
页数:12
相关论文
共 36 条
[1]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[2]  
[Anonymous], 2002, 3 REP NAT CHOL ED PR
[3]  
[Anonymous], WORLD HLTH REP 2002
[4]  
[Anonymous], 2004, WORLD HLTH REPORT 20
[5]   Perils, pitfalls, and possibilities in talking about medical risk [J].
Bogardus, ST ;
Holmboe, E ;
Jekel, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (11) :1037-1041
[6]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[7]   Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study [J].
Brindle, P ;
Emberson, J ;
Lampe, F ;
Walker, M ;
Whincup, P ;
Fahey, T ;
Ebrahim, S .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7426) :1267-1270A
[8]  
Brislin R.W., 1980, METHODOLOGY, P389
[9]   CONSORT statement: extension to cluster randomised trials [J].
Campbell, MK ;
Elbourne, DR ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441) :702-708
[10]   Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project [J].
Conroy, RM ;
Pyörälä, K ;
Fitzgerald, AP ;
Sans, S ;
Menotti, A ;
De Backer, G ;
De Bacquer, D ;
Ducimetière, P ;
Jousilahti, P ;
Keil, U ;
Njolstad, I ;
Oganov, RG ;
Thomsen, T ;
Tunstall-Pedoe, H ;
Tverdal, A ;
Wedel, H ;
Whincup, P ;
Wilhelmsen, L ;
Graham, IM .
EUROPEAN HEART JOURNAL, 2003, 24 (11) :987-1003